How to put NICE guidance into practice and improve the health and wellbeing of communities - Practical steps for local authorities (4th September 2008)
Following two stakeholder workshops in May of this year, NICE has developed a “How to” guide to implementation that aims to support Local Authorities with the implementation of NICE guidance. This guide is due to be launched at the NICE conference in December 2008. Closing date for comments is 5pm 22nd September 2008.
Consultation
Organ preservation (renal) - machine perfusion and static storage: appraisal consultation document (9th September 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of machine perfusion systems and cold static storage of kidneys from deceased donors, and to provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of machine perfusion systems and cold static storage of kidneys from deceased donors. Closing date for comments is 30th September 2008.
Consultation
Needle and syringe programmes: consultation on the draft guidance (15th September 2008)
Consultation on the draft guidance relating to Needle and syringe programmes: providing injecting equipment to people who inject drugs. Registered stakeholders are invited to comment on the draft guidance document which entails the draft recommendations. This consultation will take place between Monday 15th September and Monday 13th October 2008.
Consultation
Crohn’s disease - infliximab (review) and adalimumab: appraisal consultation (16th September 2008)
The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of infliximab and adalimumab for the treatment of Crohn's disease and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of infliximab and adalimumab. Closing date for comments is 3rd October 2008.
Consultation
Evaluation Report
Influenza - zanamivir, amantadine and oseltamivir (review): appraisal consultation (16th September 2008)
The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of amantadine, oseltamivir and zanamivir and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of amantadine, oseltamivir and zanamivir. Closing date for comments is 7th October 2008.
Consultation
Latest implementation Tools (10th September 2008)
Stroke
Slide Set
Diabetes Insulin Pump Therapy
Slide Set
Age related macular degeneration (AMD) - pegaptanib and ranibizumab
Audit Support
Costing Tool
Induction of Labour
Slide Set
Hepatitis B - entecavir
Audit Support
Costing Statement
Hepatitis B - telbivudine
Audit Support
Costing Statement
Total Wrist Replacement
Audit Support
Respiratory Trace Infections
Slide Set
Rh-D negative women - routine antenatal anti-D prophylaxis (including new product rhophylac)
Audit Support
Costing Statement
Prevention of ventilator-associated pneumonia
Audit Support
Costing Tool
Slide Set
Smoking in children
Following two stakeholder workshops in May of this year, NICE has developed a “How to” guide to implementation that aims to support Local Authorities with the implementation of NICE guidance. This guide is due to be launched at the NICE conference in December 2008. Closing date for comments is 5pm 22nd September 2008.
Consultation
Organ preservation (renal) - machine perfusion and static storage: appraisal consultation document (9th September 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of machine perfusion systems and cold static storage of kidneys from deceased donors, and to provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of machine perfusion systems and cold static storage of kidneys from deceased donors. Closing date for comments is 30th September 2008.
Consultation
Needle and syringe programmes: consultation on the draft guidance (15th September 2008)
Consultation on the draft guidance relating to Needle and syringe programmes: providing injecting equipment to people who inject drugs. Registered stakeholders are invited to comment on the draft guidance document which entails the draft recommendations. This consultation will take place between Monday 15th September and Monday 13th October 2008.
Consultation
Crohn’s disease - infliximab (review) and adalimumab: appraisal consultation (16th September 2008)
The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of infliximab and adalimumab for the treatment of Crohn's disease and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of infliximab and adalimumab. Closing date for comments is 3rd October 2008.
Consultation
Evaluation Report
Influenza - zanamivir, amantadine and oseltamivir (review): appraisal consultation (16th September 2008)
The Department of Health and the Welsh Assembly Government have asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of amantadine, oseltamivir and zanamivir and provide guidance on their use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of amantadine, oseltamivir and zanamivir. Closing date for comments is 7th October 2008.
Consultation
Latest implementation Tools (10th September 2008)
Stroke
Slide Set
Diabetes Insulin Pump Therapy
Slide Set
Age related macular degeneration (AMD) - pegaptanib and ranibizumab
Audit Support
Costing Tool
Induction of Labour
Slide Set
Hepatitis B - entecavir
Audit Support
Costing Statement
Hepatitis B - telbivudine
Audit Support
Costing Statement
Total Wrist Replacement
Audit Support
Respiratory Trace Infections
Slide Set
Rh-D negative women - routine antenatal anti-D prophylaxis (including new product rhophylac)
Audit Support
Costing Statement
Prevention of ventilator-associated pneumonia
Audit Support
Costing Tool
Slide Set
Smoking in children
Slide Set
Familial hypercholesterolaemia
Costing Tool
Lipid modification
Audit Support
Implantation of miniature lens systems for advanced age related macular degeneration
Audit Support
Type 2 diabetes (review)
Audit Support
Familial hypercholesterolaemia
Costing Tool
Lipid modification
Audit Support
Implantation of miniature lens systems for advanced age related macular degeneration
Audit Support
Type 2 diabetes (review)
Audit Support
No comments:
Post a Comment